Therapeutic misconception—a false belief that individuals will benefit from participating in research—can bias informed consent. Ethics consultants can help by engaging participants’ and researchers’ understandings of risks and benefits and by asking good questions about the influences of researchers’ enthusiasm.
AMA J Ethics. 2018;20(11):E1100-1106. doi:
10.1001/amajethics.2018.1100.
The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.
AMA J Ethics. 2017;19(2):192-198. doi:
10.1001/journalofethics.2017.19.2.pfor2-1702.
Women who are pregnant might not treat their mental illnesses because they overestimate risks of medication and underestimate risks of leaving their illness untreated.
AMA J Ethics. 2016;18(6):614-623. doi:
10.1001/journalofethics.2016.18.6.stas1-1606.
Haley Moulton, Benjamin Moulton, JD, MPH, Tim Lahey, MD, MMSc, and Glyn Elwyn, MD, PhD, MSc
Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.
AMA J Ethics. 2020;22(5):E365-371. doi:
10.1001/amajethics.2020.365.
John is one patient-sitter whose cancer and portraiture experiences illuminate what it means to witness, to express regard for another’s difficult health and health care experiences.
AMA J Ethics. 2020;22(6):E470-475. doi:
10.1001/amajethics.2020.470.
Lisa is one patient-sitter who took comfort in the permanence of portraiture amidst the uncertainties of tongue cancer. Her experience offers an abundance of lessons for art and healing.
AMA J Ethics. 2020;22(6):E482-487. doi:
10.1001/amajethics.2020.482.